NACDS letter to President Biden urges Executive Branch action and support of immediate Congressional action on PBM reforms; comes in advance of White House listening session on reforms to address harmful PBM tactics.
"We appreciate the leadership and hard work that have gone into the many bipartisan PBM reform legislative efforts this congress. We reiterate that these reforms are needed without delay."
“Americans deserve and expect protection from inflated prescription drug costs, from forced pharmacy closures, and from barriers to their pharmacy of choice that result from PBM tactics”
Following smooth transition, Medicaid patients enjoy enhanced pharmacy access
Settlement reached with the State of Washington brings to an end Washington State’s flawed pharmacy reimbursement plan; offers hope for the ability of pharmacies to continue to meet patients’ needs in Washington State and across the nation
From industry trade press, to publications serving the broader business community, to media outlets relied on by government decision-makers, important story lines about pharmacy benefit manager reform continue to generate headlines and attention across the nation.
NACDS today praised the bipartisan introduction of the Protect Patient Access to Pharmacies Act (S. 2052) – a bill that would help preserve Medicare beneficiaries’ access to their pharmacy of choice and help stop “pharmaceutical benefit manipulation” that harms patients and pharmacies alike.
Organizations representing pharmacists and pharmacies are applauding the Protect Patient Access to Pharmacies Act (S. 2052) introduced on June 21 in the U.S. Senate.
Action is essential component of PBM reform in the Medicaid program and vital for patients and the pharmacies serving them.
Organizations commend House Committee on Oversight and Accountability for hearing on PBM tactics.
